Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Medicine Acquires Guangzhou LifeTech for $8.3 Million

publication date: Oct 30, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Medicine Corporation has acquired Guangzhou LifeTech Pharmaceuticals Co. Ltd., a producer of pharmaceuticals products and TCMs, for 57 million RMB ($8.3 million) in cash plus the assumption of 89.8 million RMB ($13.2 million) in debt. China Medicine appraised LifeTech’s assets at 174 million RMB ($25.6 million), including manufacturing facilities and a portfolio of 39 TCM and Western medicine products. More details...

Stock Symbol: (OTCBB: CHME)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners